Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

The novel antiobesic HMR1426 reduces food intake without affecting energy expenditure in rats.

Ortmann S, Kampe J, Gossel M, Bickel M, Geisen K, Jähne G, Lang HJ, Klaus S.

Obes Res. 2004 Aug;12(8):1290-7.

2.

Analysis of the anorectic efficacy of HMR1426 in rodents and its effects on gastric emptying in rats.

Bickel M, Gossel M, Geisen K, Jaehne G, Lang HJ, Rosenburg R, Sandow J.

Int J Obes Relat Metab Disord. 2004 Feb;28(2):211-21.

PMID:
14663491
3.

Cardiovascular effects of conventional sulfonylureas and glimepiride.

Geisen K, Végh A, Krause E, Papp JG.

Horm Metab Res. 1996 Sep;28(9):496-507.

PMID:
8911987
4.

Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes.

Müller G, Geisen K.

Horm Metab Res. 1996 Sep;28(9):469-87. Review.

PMID:
8911985
5.

Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.

Kramer W, Müller G, Geisen K.

Horm Metab Res. 1996 Sep;28(9):464-8. Review.

PMID:
8911984
6.

Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas.

Müller G, Satoh Y, Geisen K.

Diabetes Res Clin Pract. 1995 Aug;28 Suppl:S115-37. Review.

PMID:
8529504
7.

Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.

Hammes HP, Ali SS, Uhlmann M, Weiss A, Federlin K, Geisen K, Brownlee M.

Diabetologia. 1995 Mar;38(3):269-73.

PMID:
7758871
8.

Sorbitol-accumulating pyrimidine derivatives.

Geisen K, Utz R, Grötsch H, Lang HJ, Nimmesgern H.

Arzneimittelforschung. 1994 Sep;44(9):1032-43.

PMID:
7986240
9.

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.

Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M.

Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11555-8. Erratum in: Proc Natl Acad Sci U S A 1992 Oct 1;89(19):9364.

10.

Special pharmacology of the new sulfonylurea glimepiride.

Geisen K.

Arzneimittelforschung. 1988 Aug;38(8):1120-30.

PMID:
2904269
11.

[Blood glucose-lowering acylaminoalkylbenzenesulfonamide derivatives with heterocyclic acyl residues].

Hitzel V, Geisen K, Pfaff W, Ritzel H, Weyer R.

Arzneimittelforschung. 1987 Dec;37(12):1319-23. German.

PMID:
3449057
12.

Biological activity in vivo of insulin analogues modified in the N-terminal region of the B-chain.

Cao QP, Geiger R, Langner D, Geisen K.

Biol Chem Hoppe Seyler. 1986 Feb;367(2):135-40.

PMID:
3516176
13.

Inhibition of 3H-glibenclamide binding to sulfonylurea receptors by oral antidiabetics.

Geisen K, Hitzel V, Okomonopoulos R, Pünter J, Weyer R, Summ HD.

Arzneimittelforschung. 1985;35(4):707-12.

PMID:
3925960
14.

Stabilisation of dissolved proteins against denaturation at hydrophobic interfaces.

Thurow H, Geisen K.

Diabetologia. 1984 Aug;27(2):212-8.

PMID:
6386584
15.

Results with a catheterless insulin delivery device implanted in a pancreatectomized dog.

Geisen K, Jung S, Fiedler B.

Horm Metab Res. 1983 Mar;15(3):111-6. No abstract available.

PMID:
6343212
16.
17.

[Exchange of A1-glycine in bovine insulin with L- and D-tryptophan].

Geiger R, Geisen K, Summ HD.

Hoppe Seylers Z Physiol Chem. 1982 Oct;363(10):1231-9. German.

PMID:
6754570
18.

Long-term continuous intraperitoneal insulin infusion with an implanted remote-controlled insulin infusion device.

Irsigler K, Kritz H, Hagmüller G, Franetzki M, Prestele K, Thurow H, Geisen K.

Diabetes. 1981 Dec;30(12):1072-5.

PMID:
7308587
19.

[Continuous blood glucose monitoring and infusion in freely mobile dogs (author's transl)].

Geisen K, Reisig E, Härtel D.

Res Exp Med (Berl). 1981;179(2):103-11. German.

PMID:
7280359
20.

[Insulin analogues with substitution of A1-glycine by D-amino acids and omega-amino acids (author's transl)].

Geiger R, Geisen K, Regitz G, Summ HD, Langner D.

Hoppe Seylers Z Physiol Chem. 1980 Apr;361(4):563-70. German.

PMID:
6991387
21.
22.

[Acylaminoalkyl substituted benzoic and phenylalkane acids with hypoglycaemic properties (author's transl)].

Geisen K, Hübner M, Hitzel V, Hrstka VE, Pfaff W, Bosies E, Regitz G, Kühnle HF, Schmidt FH, Weyer R.

Arzneimittelforschung. 1978;28(7):1081-3. German.

PMID:
582693
23.

[(A1-beta-Alanine) insulin].

Geiger R, Geisen K, Regitz G, Summ HD.

Hoppe Seylers Z Physiol Chem. 1976 Sep;357(9):1267-70. German.

PMID:
992580
24.

[(A1-D-alanine) insulin (author's transl)].

Geiger R, Geisen K, Summ HD, Langer D.

Hoppe Seylers Z Physiol Chem. 1975 Oct;356(10):1635-49. German.

PMID:
1213677
25.

Synthesis and characterisation of a decapeptide having LH-RH-FSH-RH activity.

Geiger R, König W, Wissmann H, Geisen K, Enzmann F.

Biochem Biophys Res Commun. 1971 Nov 5;45(3):767-73. No abstract available.

PMID:
4942725
26.
27.

[Therapy of hypophyseal dwarfism].

Schwenk A, Geisen K.

Monatsschr Kinderheilkd. 1970 Jun;118(6):240-3. German. No abstract available.

PMID:
5523646
28.

[Heat-induced secretion of somatotropin in man].

Meder R, Geisen K.

Z Kinderheilkd. 1970;108(4):297-304. German. No abstract available.

PMID:
5517760
29.

[The effect of heat on the level of human growth hormone in the serum].

Geisen K, Meder R.

Z Kinderheilkd. 1969;106(4):308-13. German. No abstract available.

PMID:
5810013
30.
31.

[Peritoneal dialysis in liver coma of a 5 year old patient].

Geisen K, Lombeck I, Sieberth HG, Weidtman V.

Z Kinderheilkd. 1967;101(1):1-6. German. No abstract available.

PMID:
5603098
33.
34.

[On standard theoretical analysis of the blood circulation. II. The persistence of the flow volume-pressure relation in the arterial system with and without regulation in dogs].

Stegemann J, Geisen K.

Pflugers Arch Gesamte Physiol Menschen Tiere. 1966;287(3):257-64. German. No abstract available.

PMID:
5235772

Supplemental Content

Loading ...
Support Center